HPGDS and chronic obstructive pulmonary disease: The results of the present investigation extend previous knowledge about GSTs and human lung which so far have mainly focused on the polymorphisms in these enzymes in protecting human lung against toxic metabolites [26] or the mRNA levels of these enzymes in the bronchial brushings of smokers or COPD patients [11,12].